Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
DLX3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Dense bone dysplasia Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 4 | 14 |
|
Dense bone dysplasia Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 4 | 14 |
|
Dense bone dysplasia NGS panel HNL Genomics Connective Tissue Gene Tests United States | 4 | 14 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Osteopetrosis and Dense bone dysplasia Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 31 | 28 |
|
Osteopetrosis and Dense bone dysplasia NGS panel HNL Genomics Connective Tissue Gene Tests United States | 31 | 28 |
|
Osteopetrosis and Dense bone dysplasia Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 31 | 28 |
|
Dense bone dysplasia Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 4 | 14 |
|
Dense bone dysplasia Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 4 | 14 |
|
Dense bone dysplasia NGS panel HNL Genomics Connective Tissue Gene Tests United States | 4 | 14 |
|
Amelogenesis Imperfecta via the DLX3 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Amelogenesis imperfecta and dentinogenesis imperfecta panel. NGS panel of 15 genes. Genologica Medica Spain | 22 | 14 |
|
Osteoporosis and bone dysplasia panel. 25-gene NGS panel. Genologica Medica Spain | 56 | 25 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 543 | 178 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.